Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB11P1 is a human pseudogene related to the protein-coding gene NDUFB11, which is a subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I)[1][3][5]. Pseudogenes are non-functional copies of genes; they may not be transcribed or translated, and typically do not produce functional protein products. Although some pseudogenes have been shown to exert regulatory effects on gene expression or participate in disease-related processes, NDUFB11P1 itself is not known to encode a functional protein, serve as a receptor, or act as a direct therapeutic target. Currently, there is no evidence that NDUFB11P1 is involved in human disease or interacts with drugs, nor is it considered a biomarker or safety concern[1][6]. Summary of Key Issue: NDUFB11P1 is mistakenly listed as a drug target or functional biomolecule; it is a pseudogene with no established protein product, therapeutic targeting, or direct biological activity. If the intention was to capture information on mitochondrial Complex I subunits, the correct entry would be "NADH:ubiquinone oxidoreductase subunit B11 (NDUFB11)" rather than the pseudogene NDUFB11P1[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B11 pseudogene 1 (NDUFB11P1).